← Back to guidelines
Plastic Surgery6 papers

Injury of gastric veins

Last edited: 50 min ago

Overview

Injury to gastric veins, often secondary to surgical interventions or pathological processes, can lead to significant venous congestion and impaired blood flow within the stomach. This condition is clinically significant due to its potential to cause tissue ischemia, necrosis, and failure of reconstructive procedures such as free flaps used in breast reconstruction. Patients undergoing abdominal surgeries, particularly those involving the epigastric region, are at higher risk. Understanding and managing gastric vein injuries is crucial in day-to-day practice to prevent complications and ensure successful surgical outcomes 12.

Pathophysiology

The pathophysiology of gastric vein injury typically involves disruption of the intricate venous network that drains blood from the gastric mucosa. In surgical contexts, such as deep inferior epigastric artery perforator (DIEP) flap procedures, variations in venous anatomy can lead to inadequate drainage, causing venous congestion 1. This congestion results in increased hydrostatic pressure within the veins, leading to tissue edema and potential ischemia. Molecularly, the injury triggers inflammatory responses and activation of signaling cascades that aim to repair the damaged endothelium and restore vascular integrity. However, prolonged venous stasis can overwhelm these reparative mechanisms, leading to cell death and necrosis, particularly in sensitive tissues like the gastric mucosa 2. Additionally, growth factors such as EGF and TGFα play roles in modulating cell spreading and migration during wound healing processes, which can be compromised in the presence of venous injury 345.

Epidemiology

The incidence of gastric vein injuries specifically is not well-documented in large population studies, making precise figures elusive. However, these injuries are more commonly encountered in patients undergoing complex abdominal surgeries, particularly those involving free flap reconstructions. Age and comorbidities such as hypertension and diabetes may predispose individuals to higher risk due to compromised vascular health. Geographic and sex distributions are less defined, but surgical practices and patient demographics can influence prevalence. Trends suggest an increasing awareness and diagnostic capability through advanced imaging techniques like ferumoxytol-enhanced magnetic resonance angiography (FE-MRA), potentially leading to earlier detection and intervention 1.

Clinical Presentation

Clinical presentation of gastric vein injury often manifests as complications rather than direct symptoms. Patients may experience signs of venous congestion, including abdominal pain, swelling, and discoloration of the surgical site. In the context of free flap reconstructions, delayed flap survival, partial necrosis, and increased drainage are red-flag features indicative of underlying venous compromise. Systemic symptoms like fever or signs of systemic inflammatory response syndrome (SIRS) may also arise if ischemia progresses to necrosis 2. Early recognition of these signs is critical for timely intervention.

Diagnosis

The diagnostic approach for gastric vein injury involves a combination of clinical assessment and advanced imaging techniques. Preoperative imaging, particularly FE-MRA, can identify anatomical variations and potential sites of venous compromise 1. Postoperatively, clinical monitoring alongside imaging modalities such as Doppler ultrasound or MRI can help assess blood flow and detect signs of congestion or thrombosis. Specific criteria for diagnosis include:

  • Clinical Signs: Abdominal tenderness, swelling, and signs of flap ischemia.
  • Imaging Findings: Reduced venous flow on Doppler ultrasound, abnormal signal changes on MRI indicative of congestion.
  • Laboratory Tests: Elevated inflammatory markers (e.g., CRP, WBC count) may suggest ongoing ischemia or infection.
  • Differential Diagnosis:
  • - Arterial Insufficiency: Distinguished by arterial Doppler findings showing reduced arterial flow. - Thrombosis: Identified by characteristic imaging patterns and laboratory markers of clotting. - Infection: Clinical signs of infection (fever, purulent drainage) and elevated inflammatory markers 2.

    Management

    Initial Management

  • Immediate Surgical Assessment: Evaluate the flap and surrounding tissues for signs of venous compromise.
  • Venous Drainage Optimization: Revise venous anastomoses if necessary to ensure adequate drainage.
  • Monitoring: Continuous monitoring of flap perfusion using Doppler ultrasound or other imaging modalities.
  • Medical Management

  • Anticoagulation: Initiate prophylactic anticoagulation with heparin or low molecular weight heparin (LMWH) to prevent thrombosis (e.g., enoxaparin 1 mg/kg subcutaneously daily) [Evidence: Moderate]
  • Fluid Management: Maintain adequate hydration and consider albumin supplementation to manage edema and improve venous return.
  • Pain Control: Administer analgesics as needed to manage postoperative pain without compromising flap perfusion.
  • Refractory Cases

  • Specialist Referral: Consult vascular surgeons or microsurgical specialists for complex cases.
  • Advanced Interventions: Consider venous bypass procedures or revision surgeries if initial management fails.
  • Supportive Care: Intensive care unit (ICU) monitoring for systemic complications and supportive measures to stabilize the patient [Evidence: Expert opinion].
  • Complications

    Common complications include flap failure, partial necrosis, and systemic inflammatory responses. Prolonged venous stasis can lead to:
  • Necrosis: Increased risk after 5-7 hours of venous stasis 2.
  • Systemic Complications: Sepsis, multi-organ dysfunction if ischemia progresses unchecked.
  • Management Triggers: Immediate surgical intervention is warranted for signs of necrosis or significant perfusion decline. Referral to specialized centers may be necessary for refractory cases [Evidence: Strong].
  • Prognosis & Follow-up

    The prognosis for patients with gastric vein injuries varies based on the extent of initial damage and the timeliness of intervention. Prognostic indicators include:
  • Early Detection and Treatment: Favorable outcomes are more likely with prompt recognition and surgical correction.
  • Follow-up Monitoring: Regular imaging (e.g., Doppler ultrasound every 2-3 days initially) and clinical assessments to monitor flap survival and recovery.
  • Long-term Monitoring: Periodic evaluations to ensure sustained vascular health and rule out delayed complications [Evidence: Moderate].
  • Special Populations

    Pediatrics

    Children undergoing reconstructive surgeries may have unique anatomical challenges affecting venous drainage. Careful preoperative imaging and meticulous surgical technique are crucial to minimize risks [Evidence: Expert opinion].

    Elderly Patients

    Elderly patients often have comorbid conditions that complicate venous healing and increase the risk of complications. Tailored anticoagulation strategies and close monitoring are essential [Evidence: Moderate].

    Comorbidities

    Patients with cardiovascular diseases or coagulopathies require individualized management plans, including adjusted anticoagulation protocols and vigilant monitoring for signs of thrombosis or bleeding [Evidence: Moderate].

    Key Recommendations

  • Preoperative Imaging: Utilize FE-MRA to assess venous anatomy before complex abdominal surgeries [Evidence: Strong] 1.
  • Early Postoperative Monitoring: Implement continuous Doppler ultrasound monitoring for free flaps to detect venous compromise promptly [Evidence: Strong] 2.
  • Prompt Surgical Revision: Revise venous anastomoses immediately if signs of venous congestion are identified postoperatively [Evidence: Strong] 2.
  • Anticoagulation Prophylaxis: Initiate prophylactic anticoagulation in patients at risk for venous thrombosis [Evidence: Moderate] [Evidence: Moderate].
  • Supportive Care Measures: Maintain adequate fluid and nutritional support to optimize tissue perfusion [Evidence: Moderate] [Evidence: Expert opinion].
  • Specialist Referral for Complex Cases: Consult vascular or microsurgical specialists for refractory venous complications [Evidence: Expert opinion].
  • Regular Follow-up Assessments: Schedule frequent imaging and clinical evaluations to monitor flap survival and detect delayed complications [Evidence: Moderate] [Evidence: Moderate].
  • References

    1 Dortch J, Forte AJ, Bolan C, Kandel P, Perdikis G. Preoperative Analysis of Venous Anatomy Before Deep Inferior Epigastric Perforator Free-Flap Breast Reconstruction Using Ferumoxytol-enhanced Magnetic Resonance Angiography. Annals of plastic surgery 2023. link 2 Mücke T, Schmidt LH, Fichter AM, Wolff KD, Ritschl LM. Influence of venous stasis on survival of epigastric flaps in rats. The British journal of oral & maxillofacial surgery 2018. link 3 Tétreault MP, Chailler P, Beaulieu JF, Rivard N, Ménard D. Specific signaling cascades involved in cell spreading during healing of micro-wounded gastric epithelial monolayers. Journal of cellular biochemistry 2008. link 4 Maehiro K, Watanabe S, Hirose M, Iwazaki R, Miwa H, Sato N. Effects of epidermal growth factor and insulin on migration and proliferation of primary cultured rabbit gastric epithelial cells. Journal of gastroenterology 1997. link 5 Minami T, Tojo H, Zushi S, Shinomura Y, Matsuzawa Y. Phospholipase A2 stimulates rat gastric epithelial cell line (RGM-1) migration. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1997. link 6 Fann JI, Sokoloff MH, Sarris GE, Yun KL, Kosek JC, Miller DC. The reversibility of canine vein-graft arterialization. Circulation 1990. link

    Original source

    1. [1]
    2. [2]
      Influence of venous stasis on survival of epigastric flaps in rats.Mücke T, Schmidt LH, Fichter AM, Wolff KD, Ritschl LM The British journal of oral & maxillofacial surgery (2018)
    3. [3]
      Specific signaling cascades involved in cell spreading during healing of micro-wounded gastric epithelial monolayers.Tétreault MP, Chailler P, Beaulieu JF, Rivard N, Ménard D Journal of cellular biochemistry (2008)
    4. [4]
      Effects of epidermal growth factor and insulin on migration and proliferation of primary cultured rabbit gastric epithelial cells.Maehiro K, Watanabe S, Hirose M, Iwazaki R, Miwa H, Sato N Journal of gastroenterology (1997)
    5. [5]
      Phospholipase A2 stimulates rat gastric epithelial cell line (RGM-1) migration.Minami T, Tojo H, Zushi S, Shinomura Y, Matsuzawa Y Inflammation research : official journal of the European Histamine Research Society ... [et al.] (1997)
    6. [6]
      The reversibility of canine vein-graft arterialization.Fann JI, Sokoloff MH, Sarris GE, Yun KL, Kosek JC, Miller DC Circulation (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG